/newsroom/taxonomy/term/15987/all en /newsroom/channels/news/mcgill-university-and-moderna-expand-collaborations-new-projects-lipid-nanoparticle-research-349107 <p>ºÚÁÏÍø±¬³Ô¹Ï today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative research projects in the area of lipid nanoparticles (LNPs). LNPs are critical components in mRNA medicines such as vaccines, as they are the primary delivery method of mRNA strands to the target cells.</p> Tue, 18 Jul 2023 13:25:38 +0000 claire.loewen@mcgill.ca 306289 at /newsroom /newsroom/channels/news/mcgill-university-joins-moderna-battle-against-global-health-threats-338610 <p>ºÚÁÏÍø±¬³Ô¹Ï has joined Moderna’s <a href="https://mrna-access.modernatx.com/">mRNA Access</a> program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through collaborative research and preclinical development. ºÚÁÏÍø±¬³Ô¹Ï is the first university in Canada to join this program as it ramps up its international rollout.</p> Wed, 23 Mar 2022 21:04:28 +0000 shirley.cardenas@mcgill.ca 287084 at /newsroom